Richard William Scalzo - 11 Jul 2022 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Senior Vice President of Accounting and Administration and Treasurer
Signature
/s/ Richard Scalzo
Issuer symbol
DYN
Transactions as of
11 Jul 2022
Net transactions value
$0
Form type
4
Filing time
13 Jul 2022, 16:38:51 UTC
Previous filing
06 Jul 2022
Next filing
15 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock Option (right to buy) Award $0 +55,000 $0.000000 55,000 11 Jul 2022 Common Stock 55,000 $8.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 11, 2022. The shares underlying the option are scheduled to vest over four years in equal monthly installments from July 1, 2022.

Remarks:

Senior Vice President of Accounting and Administration and Treasurer